Furthermore, it was identified in CRC that ROR-γt, a lineage marker for the Th17 cell population, is the downstream target of ITCH, which exerts its anti-colon-carcinogenic role by attenuating IL-17 expression [40]. The gene discussed is ITCH; the disease is colorectal carcinoma.